ETF Components for VGK - Vanguard FTSE European ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
NVS B -0.72 1.66
UL A -0.55 1.06
DEO D 0.00 0.63
ABBV D -0.91 0.60
STLA D 0.56 0.39
LYG A 2.00 0.34
BCS A 1.58 0.31
E C 0.00 0.28
FLUT D -6.08 0.27
LOGI D -0.83 0.10
QGEN C -1.37 0.07

Recent News for Vanguard FTSE European ETF & its Holdings

Date Stock Title
May 28 FLUT DraftKings, FanDuel Stocks Drop as Illinois Hikes Tax for Sports Betting
May 28 ABBV AbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024 with New Data from Its Innovative Antibody-Drug Conjugate (ADC) Platform
May 28 FLUT Online sports betting operators jolted by tax legislation in Illinois
May 28 STLA Fiat to build hybrid version of 500 at Mirafiori plant
May 28 STLA Stellantis said to propose production of hybrid version of Fiat 500 EV, Jeep Compass in Italy
May 28 UL How Unilever is embracing artificial intelligence to revolutionize food development
May 27 STLA Stellantis Plans To Build Two More Hybrid Vehicles In Italy Amid Political Tensions: Report
May 27 STLA Stellantis to introduce Italy-made hybrid versions of Fiat 500 EV, Jeep Compass
May 26 LOGI Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In Your Portfolio?
May 26 STLA Taxes vs Tariffs: How the 2024 presidential election could play out for the auto industry
May 26 ABBV Forget Nvidia, Buy This Magnificent Healthcare Stock Instead
May 25 UL Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Unilever Stock.
May 25 ABBV Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo
May 25 FLUT AI in casinos and sports betting is starting to make a lot of sense (and cents)
May 25 NVS Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio
May 25 NVS Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo
May 25 ABBV Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
May 24 NVS After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
May 24 ABBV After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
May 24 BCS Citi, Barclays, HSBC ramp up full-time return to office push
The investment seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in the major markets of Europe. The fund employs an indexing investment approach by investing all, or substantially all, of its assets in the common stocks included in the FTSE Developed Europe Index. The FTSE Developed Europe Index is made up of approximately 497 common stocks of companies located in 17 European countries-mostly companies in the United Kingdom, France, Switzerland, and Germany (which made up approximately 34%, 15%, 14%, and 13%, respectively, of the index's market capitalization as of May 31, 2013).
Stock Market Index MSCI EAFE Ftse Developed Europe Index Financials Ftse Developed Europe Index
Back to the Main VGK Page...